© 2013

Patient Surveillance After Cancer Treatment

  • Frank E. Johnson
  • Yoshihiko Maehara
  • George P. Browman
  • Julie A. Margenthaler
  • Riccardo A. Audisio
  • John F. Thompson
  • David Y. Johnson
  • Craig C. Earle
  • Katherine S. Virgo
  • History of cancer patient surveillance after curative-intent treatment

  • Inform those on the subject of cancer

  • Definitions of various terms used in the field


Part of the Current Clinical Oncology book series (CCO)

Table of contents

  1. Front Matter
    Pages i-xxi
  2. David Y. Johnson, Frank E. Johnson
    Pages 1-7
  3. Brooke Crawford, David D. Greenberg
    Pages 9-13
  4. Kim E. M. van Kessel, Sandra M. E. Geurts, André L. M. Verbeek, Ewout W. Steyerberg
    Pages 15-29
  5. David Y. Johnson, Shilpi Wadhwa, Frank E. Johnson
    Pages 39-41
  6. Béatrix Barry, Dominique De Raucourt
    Pages 43-45
  7. Torahiko Nakashima, Ryuji Yasumatsu, Shizuo Komune
    Pages 47-49
  8. Richard W. Nason, James B. Butler
    Pages 51-56
  9. David Y. Johnson, Shilpi Wadhwa, Frank E. Johnson
    Pages 57-61
  10. Shilpi Wadhwa, David Y. Johnson, Frank E. Johnson
    Pages 71-74
  11. Michael Boyer, Kate Mahon
    Pages 75-78
  12. Tokujiro Yano, Yoshihiko Maehara
    Pages 79-81
  13. Gail Darling, Yee Ung, Peter Ellis, Lorraine Martelli-Reid, Bill Evans
    Pages 83-92
  14. Shilpi Wadhwa, David Y. Johnson, Frank E. Johnson
    Pages 93-95
  15. Bernard Mark Smithers, Janine M. Thomas, Bryan H. Burmeister
    Pages 97-100
  16. Masaru Morita, Yoshihiko Maehara
    Pages 101-105
  17. Shilpi Wadhwa, David Y. Johnson, Frank E. Johnson
    Pages 107-108

About this book


Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of various terms used in the field, and how those who are interested in the topic can get more information about it from the internet. The secondary focus of the book is to publicize the need for well-designed, adequately powered randomized clinical trials comparing two (or more) surveillance strategies for each type of cancer.

The audience includes all oncologists, cancer researchers, medical economists and policy makers in government and insurance companies, and finally, interested patients.

This book is part of the Current Clinical Oncology series, which provides cutting-edge knowledge of cancer diagnosis, management, and treatment. World renowned experts share their insights in all the major fields of clinical oncology. From the fundamentals of pathophysiology to the latest developments in experimental and novel therapies, Current Clinical Oncology is an indispensable resource for today’s practicing oncologist.


Breast Cancer Cancer Surveillance Tests Cancer follow-up tests Colorectal Cancer Leukemia Liver Cancer Lung Cancer Lymphoma Melanoma Myeloma Pancreatic Cancer Prostate Cancer Renal Cancer Thyroid Cancer Uterine Cancer

Editors and affiliations

  • Frank E. Johnson
    • 1
  • Yoshihiko Maehara
    • 2
  • George P. Browman
    • 3
  • Julie A. Margenthaler
    • 4
  • Riccardo A. Audisio
    • 5
  • John F. Thompson
    • 6
  • David Y. Johnson
    • 7
  • Craig C. Earle
    • 8
  • Katherine S. Virgo
    • 9
  1. 1.Department of SurgerySaint Louis UniversitySt. LouisUSA
  2. 2.Fac. Medicine, Dept. Surgery IIKyushu UniversityFukuokaJapan
  3. 3.BC Cancer AgencyVancouverCanada
  4. 4.School of MedicineWashington UniversitySt. LouisUSA
  5. 5.St Helens Teaching HospitalUniversity of LiverpoolSt HelensUnited Kingdom
  6. 6.Sydney Cancer Centre, Sydney Melanoma UnitRoyal Prince Alfred HospitalCamperdownAustralia
  7. 7.Saint Louis University Medical CenterSaint LouisUSA
  8. 8.Dana-Farber Cancer InstituteHarvard Medical SchoolBostonUSA
  9. 9.International Atlantic Economic SocietyAtlantaUSA

About the editors

Dr. Frank E. Johnson, MD

Bibliographic information

  • Book Title Patient Surveillance After Cancer Treatment
  • Editors Frank E Johnson
    Yoshihiko Maehara
    George P Browman
    Julie A. Margenthaler
    Riccardo A. Audisio
    John F Thompson
    David Y. Johnson
    Craig C. Earle
    Katherine S. Virgo
  • Series Title Current Clinical Oncology
  • Series Abbreviated Title Current Clinical Oncology
  • DOI
  • Copyright Information Springer Science+Business Media New York 2013
  • Publisher Name Humana Press, Totowa, NJ
  • eBook Packages Medicine Medicine (R0)
  • Hardcover ISBN 978-1-60327-968-0
  • Softcover ISBN 978-1-62703-965-9
  • eBook ISBN 978-1-60327-969-7
  • Edition Number 1
  • Number of Pages XXI, 538
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Oncology
    Surgical Oncology
    Cancer Research
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology


From the reviews:

“This book discusses surveillance strategies for patients completing curative-intent primary treatment for cancer. … Members of the oncology treatment team as well as primary care health professionals who provide post-treatment follow-up survivorship care will benefit from this informative, disease-specific resource. … This is an extremely valuable and useful compilation of cancer site-specific surveillance guidelines for follow-up of asymptomatic patients who have completed primary treatment with curative intent.” (Judith G. Abramson, Doody’s Book Reviews, September, 2013)

“Patient Surveillance After Cancer Treatment is a well-written, well-organized reference designed to speak to any practicing oncologist or primary care provider that follows cancer patients after treatment for curative intent. … This is a great text and reference to any clinically practicing oncologist, primary care provider, survivorship program, and training physician of any level. Patient Surveillance After Cancer Treatment will continue to prove itself useful and will be readily available in our library.” (Nima Nabavizadeh and David Elliott, Journal of Radiation Oncology, Vol. 2 (3), September, 2013)